ASTM Partial Thromboplastin Time

ASTM Partial Thromboplastin Time (PTT) testing is a method used to evaluate the coagulation properties of medical devices that come into contact with blood. This test measures the time it takes for a blood sample to clot in the presence of a medical device, ensuring that the device does not adversely affect the blood’s natural clotting process. Ensuring proper coagulation is crucial for devices used in surgeries, transfusions, and other medical procedures.

Why This Testing is Performed

The primary reason for conducting ASTM PTT testing is to ensure that medical devices do not interfere with the blood’s natural clotting mechanism. This is particularly important for devices used in surgeries, transfusions, and other medical procedures where proper blood coagulation is critical. By evaluating the coagulation properties, manufacturers can ensure that their devices are safe and effective for use in medical settings.

Have you tried our Test Navigator Tool? Try it now

Steps in Conducting This Test

1. Preparation: Prepare the medical device according to the manufacturer’s guidelines.
2. Sample Collection: Collect from a donor or source a plasma sample from a reputable testing supply vendor.
3. Inoculation: Introduce the human plasma into a testing apparatus containing the medical device.
4. Incubation: Incubate the sample-device mixture under controlled conditions.
5. Evaluation: Measure the time it takes for the blood to clot using a coagulometer or similar device.
6. Interpretation: Compare the clotting time to established benchmarks to determine if the device meets the required coagulation standards.

Standards, Guidance, and Regulations

When conducting ASTM PTT testing, it is essential to follow specific standards and guidelines:

• ASTM F2382: This standard test method provides detailed instructions for performing PTT testing on medical devices.
• ISO 10993-4: This international standard provides guidelines for hemocompatibility testing of medical devices, including the PTT assay.
• FDA Guidance: The U.S. Food and Drug Administration (FDA) provides specific guidance on validating the coagulation properties of medical devices.